The drug is expected to be approved within the next month. It's still not going to be anywhere near as effective as getting vaccinated to begin with. But on balance, they do tend to reduce the risks of covet 19.
Vox’s Umair Irfan explains how a new pill that might soon be authorized by the FDA could fill major gaps in treating Covid-19.
Today’s show was produced by Haleema Shah and Will Reid, edited by Matt Collette, engineered by Efim Shapiro, fact-checked by Laura Bullard and hosted by Sean Rameswaram.
Transcript at vox.com/todayexplained
Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices